<< Read Full Article

AMAG: FDA Delays Feraheme Decision

Stock quotes in this article: AMAG , CRME  

AMAG Pharmaceuticals(AMAG Quote) expects the U.S. Food and Drug Administration to make its approval decision on the company's iron replacement therapy Feraheme within the next few days, the company said Monday night.

The FDA's decision was supposed to come Monday but has been delayed for administrative reasons, said AMAG, based on the company's contact with the agency in recent days.

The FDA has not requested any additional information from AMAG and no outstanding issues remain regarding Feraheme, according to the company. ...

<< Read Full Article

Recent Comments

Loading .....




Dow Jones S&P 500 NASDAQ 10-Year Note
10,337.05 1,095.94 2,183.73 34.23
Oil *
72.45
UP
51.08
UP
4.01
UP
10.74
UP
0.31
10 Yr
3.42%
SPDR Gold
110.84
+0.50%
+0.37%
+0.49%
+0.91%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services